Recordati has launched its premature ejaculation treatment Fortacin as an OTC product in Germany following an EU-wide switch through the European Medicines Agency’s centralized procedure.
While the European Commission in August approved the reclassification of Fortacin all 27 EU member states, plus in the European Economic Area countries Iceland, Liechtenstein and Norway, HBW Insight understands that German consumers are the first to be able to purchase the product without a prescription
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?